Health Effects & Risks of Kratom, Opioids & Other Natural Occurring Medicines | Dr. Chris McCurdy
Episode
164 min
Read time
2 min
Topics
Productivity, Health & Wellness, Leadership
AI-Generated Summary
Key Takeaways
- ✓Product differentiation matters: Traditional kratom leaf products differ fundamentally from concentrated extracts and semi-synthetic isolates like seven-hydroxymitragynine. Leaf material requires bodily extraction of compounds, while concentrates deliver pre-extracted alkaloids rapidly into the bloodstream, creating vastly different pharmacokinetic profiles and risk levels comparable to moving from light beer to Everclear in alcohol concentration.
- ✓Multi-system pain relief mechanism: Kratom simultaneously activates opioid receptors, serotonergic pathways, and adrenergic systems—three pain-processing mechanisms never combined in conventional medicine. This tripartite action allows lower doses per system while maintaining efficacy. Users consistently report that less is more, suggesting the plant's alkaloid combination provides relief without requiring high doses on any single pathway.
- ✓Age restrictions essential: Brain development continues until age twenty-four to twenty-five, making kratom use particularly risky for younger populations. Most responsible regulatory frameworks set minimum ages at eighteen or twenty-one years old. No traditional use exists among young people in Southeast Asia, where adult laborers consume it for stamina and pain management during outdoor work in harsh tropical conditions.
- ✓Respiratory depression from isolates: Seven-hydroxymitragynine products cause respiratory depression equivalent to prescription opioids in animal studies, completely reversible with naloxone. These semi-synthetic derivatives sold as kratom-derived products represent pure opioid activity without the plant's protective multi-system effects. Current FDA dietary ingredient rules create loopholes allowing these dangerous isolates into commerce alongside traditional leaf products.
- ✓Serving size confusion drives harm: Products containing multiple servings in single bottles create overdose risk when consumers ignore fine print. A bottle labeled nine servings consumed at once delivers nine times intended exposure. Emergency department cases often involve users unfamiliar with serving calculations, particularly when products resemble familiar energy shots, leading to stacked dosing before effects manifest.
What It Covers
Dr. Chris McCurdy explains kratom's complex pharmacology, distinguishing traditional leaf products from dangerous concentrated derivatives. He covers kratom's effects on opioid, serotonin, and adrenergic systems, usage patterns among twenty million daily US users, and critical safety concerns regarding synthetic isolates.
Key Questions Answered
- •Product differentiation matters: Traditional kratom leaf products differ fundamentally from concentrated extracts and semi-synthetic isolates like seven-hydroxymitragynine. Leaf material requires bodily extraction of compounds, while concentrates deliver pre-extracted alkaloids rapidly into the bloodstream, creating vastly different pharmacokinetic profiles and risk levels comparable to moving from light beer to Everclear in alcohol concentration.
- •Multi-system pain relief mechanism: Kratom simultaneously activates opioid receptors, serotonergic pathways, and adrenergic systems—three pain-processing mechanisms never combined in conventional medicine. This tripartite action allows lower doses per system while maintaining efficacy. Users consistently report that less is more, suggesting the plant's alkaloid combination provides relief without requiring high doses on any single pathway.
- •Age restrictions essential: Brain development continues until age twenty-four to twenty-five, making kratom use particularly risky for younger populations. Most responsible regulatory frameworks set minimum ages at eighteen or twenty-one years old. No traditional use exists among young people in Southeast Asia, where adult laborers consume it for stamina and pain management during outdoor work in harsh tropical conditions.
- •Respiratory depression from isolates: Seven-hydroxymitragynine products cause respiratory depression equivalent to prescription opioids in animal studies, completely reversible with naloxone. These semi-synthetic derivatives sold as kratom-derived products represent pure opioid activity without the plant's protective multi-system effects. Current FDA dietary ingredient rules create loopholes allowing these dangerous isolates into commerce alongside traditional leaf products.
- •Serving size confusion drives harm: Products containing multiple servings in single bottles create overdose risk when consumers ignore fine print. A bottle labeled nine servings consumed at once delivers nine times intended exposure. Emergency department cases often involve users unfamiliar with serving calculations, particularly when products resemble familiar energy shots, leading to stacked dosing before effects manifest.
Notable Moment
McCurdy reveals that an estimated twenty million Americans use kratom daily, not annually, based on import data showing nearly two thousand metric tons entering monthly in twenty nineteen. This massive user base remains largely invisible to medical professionals who lack coding systems to track kratom-related adverse events in FDA databases.
Episode Transcript
Welcome to the Huberman Lab Podcast, where we discuss science and science based tools for everyday life. I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guest today is doctor Chris McCurdy. Doctor Chris McCurdy is a professor of medicinal chemistry at the University of Florida, where he directs research on natural products and their pharmacologic effects. Most recently, the plant derived compound kratom, which is readily sold in The US and around the world, and is now used by tens of millions of people daily, and those numbers are increasing fast. Doctor McCurdy's research focuses on understanding how kratom interacts with our nervous system and affects our physiology and behavior. He also studies its potential for addiction. During today's episode, we discuss the complex effects of kratom and its relationship to the opioid system. Doctor McCurdy explains how kratom's active compounds work in the brain, why it shares certain similarities to opioid drugs, and critically, how kratom products available in The US and elsewhere are largely derivatives and isolates of the kratom leaf, which is very different in terms of the effects it produces when compared to the traditional leaf products. And unfortunately, that has confused and in many cases harmed consumers. So today, you'll learn about kratom's effects at different doses and when it's sourced in different ways. You'll learn about how it can be a stimulant, how it can increase focus, how it can be a painkiller, how it can increase euphoria, but also its strong potential for addiction. You'll also learn what is known about kratom in terms of its ability to help people transition off traditional opioid drugs. It has been shown to be effective for that. However, we are also going to explain the potential harms of kratom, in particular in young people whose brains are still developing, and in people that don't have a prior opioid addiction. Our discussion about kratom also opens up a broader discussion about other plant alkaloids that have medicinal properties, including those found in things like cocoa and 100% chocolate. And we discussed the incredible history of soft drinks like Coca Cola, Pepsi, seven Up, and Doctor Pepper, which believe it or not, were originally developed as pharmacologic tools before becoming the ultra popular beverages that we're familiar with today. So I realize many people have heard about Kratom, but also many of you perhaps have not. What everyone should know, however, is that kratom products are pretty much everywhere now. You can find them in supermarkets, convenience stores, online, and they're sold under the pretense of having very specific effects related to energy, pain management, or mood. But by the end of today's episode, you'll have a thorough understanding of how this plant compound actually works. Yes, its potential effects, but also its serious risks. Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford. It is, however, part …
Get the full transcript (26,144 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
You just read a 3-minute summary of a 161-minute episode.
Get Huberman Lab summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from Huberman Lab
Essentials: Genes & the Inheritance of Memories Across Generations | Dr. Oded Rechavi
Sep 10 · 35 min
Eye on AI
Real AI Transformation Costs HALF of Everyone's Salary for 2 Years | Chris Blackburn, Liatrio
Jul 30
More from Huberman Lab
How Mitochondria Control Your Metabolism | Dr. Jared Rutter
Sep 7 · 123 min
Product School Podcast
Zapier VP of Product on Orchestrating 800+ AI Agents to Manage Everything | Chris Geoghegan | E286
Mar 4
More from Huberman Lab
We summarize every new episode. Want them in your inbox?
Essentials: Genes & the Inheritance of Memories Across Generations | Dr. Oded Rechavi
How Mitochondria Control Your Metabolism | Dr. Jared Rutter
Essentials: Use Sleep to Enhance Learning, Memory & Emotional State | Dr. Gina Poe
How to Accelerate Learning & Improve Education | Joe Liemandt
Essentials: Diet & Nutrition for Mental Health | Dr. Chris Palmer
Similar Episodes
Related episodes from other podcasts
Eye on AI
Jul 30
Real AI Transformation Costs HALF of Everyone's Salary for 2 Years | Chris Blackburn, Liatrio
Product School Podcast
Mar 4
Zapier VP of Product on Orchestrating 800+ AI Agents to Manage Everything | Chris Geoghegan | E286
The Partially Examined Life
Feb 8
PEL Presents PvI#111: God Smites Elijah Dann
The Changelog
Nov 21
NOT a swarm! (Friends)
Software Engineering Daily
Sep 3
Moving Beyond RAG with Precomputed Context
Explore Related Topics
This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into Huberman Lab.
Every Monday, we deliver AI summaries of the latest episodes from Huberman Lab and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime